BRPI0906787A2 - Uso de um extrato de proteína ribossômica e opcionalmente um adjuvante, e, composição. - Google Patents

Uso de um extrato de proteína ribossômica e opcionalmente um adjuvante, e, composição.

Info

Publication number
BRPI0906787A2
BRPI0906787A2 BRPI0906787-6A BRPI0906787A BRPI0906787A2 BR PI0906787 A2 BRPI0906787 A2 BR PI0906787A2 BR PI0906787 A BRPI0906787 A BR PI0906787A BR PI0906787 A2 BRPI0906787 A2 BR PI0906787A2
Authority
BR
Brazil
Prior art keywords
adjuvant
optionally
composition
ribosomal protein
protein extract
Prior art date
Application number
BRPI0906787-6A
Other languages
English (en)
Inventor
Manuel Soto Alvarez
Daniel Ruiz Abánades
Carlos Alonso Bedate
Original Assignee
Laboratórios Leti S L Unipersonal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratórios Leti S L Unipersonal filed Critical Laboratórios Leti S L Unipersonal
Priority claimed from PCT/EP2009/050344 external-priority patent/WO2009092652A1/en
Publication of BRPI0906787A2 publication Critical patent/BRPI0906787A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0906787-6A 2008-01-18 2009-01-14 Uso de um extrato de proteína ribossômica e opcionalmente um adjuvante, e, composição. BRPI0906787A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2192808P 2008-01-18 2008-01-18
EP08100634 2008-01-18
PCT/EP2009/050344 WO2009092652A1 (en) 2008-01-24 2009-01-14 Inhaler

Publications (1)

Publication Number Publication Date
BRPI0906787A2 true BRPI0906787A2 (pt) 2015-08-18

Family

ID=39471089

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0906787-6A BRPI0906787A2 (pt) 2008-01-18 2009-01-14 Uso de um extrato de proteína ribossômica e opcionalmente um adjuvante, e, composição.

Country Status (20)

Country Link
US (1) US20110020405A1 (pt)
EP (2) EP2231700B1 (pt)
JP (2) JP2011509968A (pt)
CN (1) CN101977930B (pt)
AP (1) AP3007A (pt)
AU (1) AU2009204849B2 (pt)
BR (1) BRPI0906787A2 (pt)
CA (1) CA2712475A1 (pt)
CO (1) CO6280495A2 (pt)
DK (1) DK2231700T3 (pt)
ES (1) ES2486365T3 (pt)
HK (1) HK1150291A1 (pt)
HR (1) HRP20140447T1 (pt)
MA (1) MA32080B1 (pt)
MX (1) MX2010007831A (pt)
PL (1) PL2231700T3 (pt)
PT (1) PT2231700E (pt)
RU (1) RU2521499C2 (pt)
WO (1) WO2009090175A1 (pt)
ZA (1) ZA201005143B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
US9187751B2 (en) 2010-11-10 2015-11-17 Laboratorios Leti, S.L. Adjuvant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500437B1 (en) * 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ES2326174T3 (es) * 1998-12-23 2009-10-02 Laboratorios Leti, S.L. Gen quimerico que codifica los determinantes antigenicos de cuatro proteinas de l. infantum.
ES2169995B1 (es) * 2000-04-17 2003-12-01 Leti Lab Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
US20030072714A1 (en) * 2001-10-12 2003-04-17 Magill Alan J. Microfluidized leishmania lysate and methods of making and using thereof

Also Published As

Publication number Publication date
RU2010134427A (ru) 2012-02-27
EP2231700B1 (en) 2014-05-07
US20110020405A1 (en) 2011-01-27
DK2231700T3 (da) 2014-07-14
WO2009090175A1 (en) 2009-07-23
ES2486365T3 (es) 2014-08-18
JP2011509968A (ja) 2011-03-31
AP2010005333A0 (en) 2010-08-31
JP2015180638A (ja) 2015-10-15
HRP20140447T1 (hr) 2014-07-04
HK1150291A1 (en) 2011-11-18
RU2521499C2 (ru) 2014-06-27
AU2009204849A1 (en) 2009-07-23
EP2570427A1 (en) 2013-03-20
AP3007A (en) 2014-10-31
CA2712475A1 (en) 2009-07-23
CN101977930A (zh) 2011-02-16
PT2231700E (pt) 2014-07-31
EP2231700A1 (en) 2010-09-29
PL2231700T3 (pl) 2014-09-30
CN101977930B (zh) 2014-12-17
AU2009204849B2 (en) 2013-10-03
MX2010007831A (es) 2011-06-20
ZA201005143B (en) 2011-12-28
MA32080B1 (fr) 2011-02-01
CO6280495A2 (es) 2011-05-20

Similar Documents

Publication Publication Date Title
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0919193A2 (pt) Uso de lipídeo, e, composição nutricional
BR112012002349A2 (pt) composto,e, uso do mesmo
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BRPI1011423A2 (pt) composição injetável, kit e método cosmético.
BRPI0814420A2 (pt) composição, e, uso de álcool alcoxilado.
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0921389A2 (pt) seringa de um só uso, de inutilização automática
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
BRPI0920263A2 (pt) composto, uso do composto, composição, e, método
BRPI1014034A2 (pt) formulação e seu uso, composição, solução injetável e kit.
BRPI0810022A2 (pt) Álcool alcoxilado, composição, e, uso de um álcool alcoxilado
BRPI1005670A8 (pt) composições adjuvantes e processos de uso.
BRPI0911252A2 (pt) método, extrato, e, composição.
BRPI0915134A2 (pt) composto, e, uso de um composto
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0909769A2 (pt) Composição não-viva contendo carboidrato, e, uso da mesma
BRPI0919412A8 (pt) composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo.
BRPI1006996A2 (pt) composição, método e uso
BRPI0920953A2 (pt) dispositivo de manutenção, e uso do mesmo.
BRPI0913175A2 (pt) artigo antibalístico, e, uso do mesmo.
BRPI0919216A2 (pt) poliuretano, e, uso de um poliuretano

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]